Morgan Stanley analyst Sarita Kapila initiated coverage of AstraZeneca (AZN) with an Overweight rating and 14,500 GBp price target The firm ...
Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss the Phase 1b/2 ...
Ascendis Pharma UK, a subsidiary of the global biopharmaceutical company with a portfolio of products and product candidates specialising in rare endocrine diseases, has opened a UK office and ...
News Medical on MSN22h
Single dose of antibody shields macaques from severe H5N1 influenzaNational Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...
Sopra Steria is one of the only five providers to achieve a Best-in-class overall rating in 2024 as supplier of ServiceNow-related servicesPAC highlighted Sopra Steria's ability to extend ServiceNow ...
A sizeable improvement was found in the prevalence of American adults aged 65 and older without disabilities -- including memory, hearing, visual, and functional disabilities or limitations in ...
AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 18,619.50 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...
The issuer is solely responsible for the content of this announcement.
Roche Holding AG Akt 0.65% CHF232.25B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback